Post-COVID-19 Condition has High Prevalence in Patients with Immune-mediated Inflammatory Diseases and Negatively Impacts Quality of Life
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Overview
Randomized trial finds post-COVID-19 condition negatively affects quality of life in patients with immune-mediated inflammatory diseases, suggesting treatment considerations are needed.
Key Points
This research aims to investigate the prevalence and impact of post-COVID-19 condition on the quality of life in patients with immune-mediated inflammatory diseases.
Adult patients with immune-mediated inflammatory diseases participated at a university outpatient center.
Data were collected through questionnaires assessing individual COVID-19 history and persistent symptoms.
Quality of life was measured using standardized patient-reported outcome measures.
51% of participants reported a positive COVID-19 history, mostly mild cases.
Global quality of life scores were significantly lower in patients with post-COVID-19 condition (mean 61.9) compared to those without (mean 71.5), P=0.03.
25% met WHO criteria for post-COVID-19 condition, and 23% continued to experience symptoms at data acquisition.